Antibiotics have saved countless lives since their introduction nearly a century ago. But new research suggests these powerful drugs may have a surprisingly long imprint on our gut microbiome, the community of bacteria living inside us.

A large new Swedish study has found that certain antibiotics may influence the gut microbiome for as long as four to eight years after treatment.

These findings add to growing evidence that medications designed to fight infection can have lasting effects on trillions of microbes that help regulate digestion, metabolism and immune function.

Even a single course of antibiotics appeared to leave a detectable footprint years later.

Researchers led by scientists at Uppsala University analyzed health and biological data from nearly 15,000 adults in Sweden in order to investigate how past antibiotic use relates to the composition of the gut microbiome.

Their work drew on Sweden's comprehensive national prescription registry, which records all antibiotics dispensed at pharmacies and linked that information to gut microbiome data from national biobanks at Uppsala University and Lund University.

The results showed clear differences. Participants who had taken antibiotics tended to have lower microbial diversity, meaning fewer types of bacteria were living in their gut than those who had not taken the drugs. Diversity in the microbiome is generally considered a marker of resilience and overall gut health. But even a single course of antibiotics appeared to leave a detectable footprint years later.

“We can see that antibiotic use as far back as four to eight years ago is linked to the composition of a person's gut microbiome today. Even a single course of treatment with certain types of antibiotics leaves traces,” Gabriel Baldanzi, first author of the study and a former doctorate student at Uppsala University, said in a press release.

The extent of these changes depended heavily on the type of antibiotic used. The researchers observed the most pronounced effects among people who had taken clindamycin, fluoroquinolones or flucloxacillin. In contrast, penicillin, one of the most commonly-prescribed antibiotics in Sweden, was linked to smaller and shorter lasting microbiome species disruptions.

For instance, fluoroquinolones, which are often prescribed for urinary tract and respiratory infections, were linked to about 20 fewer species on average, along with a shift in many other microbes. The researchers also observed that the gut microbiome appears to recover partially over time, with the fastest rebound occurring within the first two years after antibiotic use. After that point, recovery slowed and, in some cases, never fully returned to previous levels.

“The strong link between the narrow-spectrum flucloxacillin and the gut microbiome was unexpected, and we would like to see this finding confirmed in other studies,” said Tov Fall, PhD, Professor of Molecular Epidemiology at Uppsala University and the study's principal investigator.

The results may help explain why heavy antibiotic use has been linked to certain health conditions, including type 2 diabetes, gastrointestinal infections and inflammatory bowel disease.

The results may help explain why previous research had linked heavy antibiotic use to certain health conditions, including type 2 diabetes, gastrointestinal infections and inflammatory bowel disease. Scientists suspect that disruptions in the gut microbiome could play a role, though the relationship is still being studied.

This study has some limitations. For example, each participant's microbiome was sampled only once, and antibiotic records covered an eight-year window. The team is now collecting second microbiome samples from nearly half of the participants to better understand how long recovery may take and why some microbiomes appear more vulnerable than others.

The researchers emphasize that antibiotics remain an essential medicine. But they also offer a reminder that even short-term treatments can have long-term biological consequences. The suggestion isn't to avoid antibiotics when needed, but to appreciate that these powerful drugs may have lasting ripple effects.

The study is published in Nature Medicine.